A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma

• Status: Completed
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if the Punctal Plug Delivery System is safe and effective in controlling intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mati Therapeutics Inc.
• Treatments: Latanoprost

Criteria

Inclusion Criteria:

• Over 18 yrs with ocular hypertension or open-angle glaucoma

• Subjects who have a best-corrected visual acuity of 20/100 or better.

Exclusion Criteria:

• Subjects who wear contact lenses.

• Uncontrolled medical conditions

• Subjects requiring chronic topical artificial tears, lubricants, and/or requiring any other chronic topical medications.

• Subjects who have a history of chronic or recurrent inflammatory eye disease.